FREE CASE EVALUATION: 1-800-632-1404

Tens of thousands of women receive a transvaginal mesh (TVM) device each and every year from numerous suppliers: American Medical Systems, Bard, Boston Scientific, Ethicon,Gynecare, and Johnson & Johnson.  Thousands of women have been injured through no fault of their own, including vaginal erosion, pain, urinary problems, bleeding, infection and more. Our attorneys are representing women in all fifty states and Canada who have been injured.  For a free case evaluation, call 1-800-632-1404.

We are honored to have two women on staff ready and willing to discuss the facts of your case with you as often as needed.

FDA Issues Mandate

The FDA issued a mandate this week requiring the manufacturers of transvaginal mesh (TVM) products, including American Medical Systems, Bard, Boston Scientific, Ethicon,Gynecare, and Johnson & Johnson, to study the risks and complications of device usage. As a service to the public at large, these are four separate news sources reporting on this pandemic that is affecting thousands of women.

Increased reports of complications have prompted the US Food and Drug Administration (FDA) to order new postmarket surveillance (522) studies of surgical mesh implants used to treat pelvic organ prolapse and stress urinary incontinence.

The FDA is also considering reclassifying urogynecologic surgical mesh used for transvaginal repair of pelvic organ prolapse from Class II to Class III, a higher-risk category that would require clinical trials before approval. 

This issue has been reported by Modern Medicine.

Our team of attorneys is reviewing case evaluations for women across the country who have received TVM and TVT products from manufactures such as C.R. Bard, Avaulta, Boston Scientific, and Johnson & Johnson’s Ethicon.

If you need help from a transvaginal mesh device injury, call us today for help.

The Problem

In 2008, the FDA first released concerns about the safety of transvaginal placement of mesh. From 2008 to 2010, the FDA received three to five times as many adverse reports associated with mesh used for pelvic organ prolapse repair than what agency received from 2005 to 2007 (nearly 1,000 reports of adverse events were received from 2005-2007).

Many of these patients complain because of erosion or contraction of the mesh material (which has been described as being of a similar material as Rubbermaid storage containers).  The erosion leads to bleeding, severe pelvic pain, painful (or impossible) sexual performance and a recurrence of urinary problems.

In July 2011, the Food and Drug Administration (FDA) issued an update related to what it called ‘serious complications’ related to the use of vaginal mesh for treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI).  It is now known that complications linked to transvaginal placement of surgical mesh in SUI and POP patients are not rare and can require multiple surgeries to correct problems related to the use of surgical mesh. In fact, the FDA now says that additional surgeries may actually not be able to repair damage caused by implantation of the mesh.

In other words, the side effects of the mesh placement may be permanent.  These complications from transvaginal placement of surgical mesh include:

• -Erosion of the implanted mesh
• -Infection and/or bleeding
• -Pain, including pain during sexual intercourse
• -Problems with organs near the implantation site

Helping You

You may have experienced mesh erosion, bleeding, urinary infections, vaginal scarring, pain during sexual intercourse, failure to conduct sexual intercourse and more. A physician may have tried to remove the mesh and been unable to do so. You may be in excruciating pain, and need help. We are offering free case evaluations to the general public across the United States and Canada. Manufacturers we consider include American Medical Systems, Bard, Boston Scientific, Ethicon,Gynecare, and Johnson & Johnson.

If you received a transvaginal mesh / sling and have been injured, you may be entitled to monetary compensation. Problems include pain, inability to have intercourse,bleeding, mesh growth into the body, mesh erosion, and more. Problems could be irreversible. Please fill out the form to the right or call us so that we can provide you with forms to evaluate your potential case immediately.

We are accepting case evaluations nationwide and in Canada, as well.  Please do not hesitate or delay in contacating TVM / TVT Sling and transvaginal mesh attorneys :

CALL: 1-800-632-1404

EMAIL: clicking here

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

• Comments

FOR A FREE CASE EVALUATION, CALL 1-800-632-1404

If you took Actos® (pioglitazone) for a year or longer and have been diagnosed with bladder cancer, call the Actos bladder cancer lawyers with our firm at 1-800-632-1404. Our firm is currently reviewing cases involving persons who took Actos® for control of blood sugar.

SIDE EFFECTS POSSIBLE 

Actos® is a pioglitazone drug used to treat type 2 diabetes. Pioglitazone is an insulin sensitizer that works by making the tissues more sensitive to the effects of insulin. Bladder Cancer and Congestive Heart Failure are two potential side effects of Actos®.

Bladder Cancer

Bladder cancer originate sin the cells that line the urinary tract and is the fourth most common cancer in men and the tenth most common cancer is women. The most presenting symptom of bladder cancer is blood in the urine but patients suffering from bladder cancer often report other complaints such as frequent urination or burning with urination. Treatment of bladder cancer depends on whether the tumor is superficial or invasive, low or high grade, and whether there is local or distant spread. Additional treatment may be required if the tumor is very large, high grade and/or multifocal – more than one tumor exists in more than one location of the bladder. If the patient is unfit for surgery, a combination radiation and chemotherapy is generally used. Those who undergo this combination procedure may experience side effects from both the chemotherapy and radiation.

Congestive Heart Disease

Another potential side effect of Actos® is Congestive Heart Disease. A person suffers from congestive heart failure when the heart fails to pump sufficient blood required to meet the body’s needs. Symptoms of congestive heart disease include muscular fatigue, breathlessness during activities and rest, unexplained wheezing or coughing, swelling of abdomen, legs or ankles. Elder patients who have been prescribed Actos® are more likely to suffer from congestive heart disease.

Other Potential Side Effects

Other side effects of Actos® could include the following, and we would invite inquiries from all:

• allergic reaction (as evidenced by hives; swelling of face, neck or throat);
• shortness of breath;
• swelling or rapid weight gain;
• chest pain, general ill feeling;
• nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools;
• jaundice (yellowing of the skin or eyes);
• blurred vision;
• increased thirst or hunger, urinating more than usual; or
• pale skin, easy bruising or bleeding, weakness;
• sneezing, runny nose, cough or other signs of a cold;
• headache;
• gradual weight gain;
• muscle pain; or
• tooth problems.

BACKGROUND

Since 1999, Actos® has been prescribed as part of an overall treatment regimen for controlling blood sugar in diabetic patients. In recent years it has also been prescribed as a diabetes preventative in those who show the early signs of the disease. In September 2010, the U.S. Food and Drug Administration (FDA) began a safety review of Actos® when new data was discovered that suggested a link to increased risk of bladder cancer.

The risk of bladder cancer is MUCH HIGHER for those that take the drug at higher cumulative doses and for longer periods of time. This increased risk is also greater in men than in women. The FDA has issued a warning of the elevated risk to patients who have been taking Actos®, but added that patients should not stop taking Actos® unless instructed to do so by their physicians. The active ingredient in Actos® is also contained in other drugs, namely Actoplus Met®, Actoplus Met XR®, and Duetact®.

Although Actos® continues to remain on the shelves of drug stores in the United States, the drug is under a long-term observational study by the FDA. France suspended the drug and Germany recommended not to start new patients on the drug due to mounting concerns for their citizens.

RISK OF BLADDER CANCER

In June of this year the U.S. Food & Drug Administration (FDA) issued a warning about the popular diabetes drug Actos(pioglitazone). The FDA had found that the use of pioglitazone for more than a year may be linked to an increased risk of bladder cancer.

SYMPTOMS OF BLADDER CANCER

Common symptoms of Actos®-related bladder cancer may include:

• ■Blood in urine, sometimes creating a change in urine color
• ■Frequent urination
• ■Painful urination
• ■Urinary tract infection

If you or a loved one developed bladder cancer during or after taking Actos®, Actoplus Met®, Actoplus Met XR®, or Duetact®, call us now at 1-800-632-1404 or SUBMIT A SHORT CASE FORM HERE for a free, no obligation, evaluation of your case.

HERE TO HELP.

If you are interested in claims for Actos, an Actos lawsuit, information on an Actos class action, or want to speak with anActos attorney, please call us today at 1-800-632-1404.

Members of our firm are attorneys currently representing clients who have taken several prescription drugs and claim injuries associated with those drugs, including Topamax®, Wellbutrin®, Fosamax®, and Actos®. Members of the firm also represent clients across the globe pertaining to medical device failures, including the Advanced Bionics HiRes90k® cochlear implant , the TVM / TVT transvaginal mesh – sling and the DePuy hip implant. For a free case evaluation, please contact:

CALL US TOLL FREE: (800) 632-1404

EMAIL: click here

FILL OUT THIS FORM:

NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

• Comments

TO DISCUSS YOUR NEEDS, PLEASE CALL 901-527-2125

Our team of attorneys handle business litigation needs across Tennessee, including in Memphis, Jackson, Nashville and beyond. We handle commercial litigation cases for businesses both large and small on a variety of topics.

INDUCEMENT IN FRAUD.

In Alabama, Sunshine Mills, a pet food manufactuerr, and software company Ross Systems entered into discussions concerning Sunshine’s desire to purchase a new inventory management software system. After presentations, representations and discussions, Sunshine agreed to purchase a new system from Ross. Once received, Sunshine soon learned that the Ross software was filled with errors, and locked up its network on multiple occasions. In the end, Sunshine had no choice but to incur substantial costs to go back to its old software system. The company incurred $2.0 million in costs, including $1.3 million paid to Ross. Sunshine hired attorneys to file a claim against Ross for fraud in the inducement, and Sunshine prevailed at trial, as the jury awarded $61.38 million in damages.

Our team of attorneys can handle a similar case in Tennessee on behalf of businesses for fraud in the inducement, breach of contract and other theories.  Our team is also able to defend businesses that have been sued for such a claim. The first step is for a business to contact our team of attorneys for confidential help at 901-527-2125.

OVERVIEW.

Our team of attorneys help businesses in both filing claims against other businesses and defending businesses that have been sued.  Types of cases that our team of attorneys will handle for businesses include but are not limited to the following: breach of fiduciary duty, fraud, misrepresentation, breach of contract, interference with contractual relations, securities fraud, franchise disputes, corporate management issues, commission disputes, and general business litigation support.

If you find yourself or your company in a business related dispute, it is wise to seek early counsel from a qualified and experience business torts attorney. To increase your chances of a successful legal case, it is important to have a competent business torts litigator on your side. While you may be reluctant to take that next step in involving legal counsel in an already messy business dispute, it is truly the best and only way to adequately protect your interests.

PLEASE CALL US TODAY FOR A CONFIDENTIAL MEETING.

TELEPHONE: 901-527-2125

EMAIL: Click Here

FILL OUT THIS FORM:

• Comments

FOR A FREE CASE EVALUATION, CALL 1-800-632-1404

If you took Actos® (pioglitazone) for a year or longer and have been diagnosed with bladder cancer, call the Actos bladder cancer lawyers with our firm at 1-800-632-1404. Our firm is currently reviewing cases involving persons who took Actos® for control of blood sugar.

CONGESTIVE HEART FAILURE

One of the allegations against Actos is that it could cause congestive heart failure.  Congestive heart failure results when either the left or right side of the heart fails to pump enough blood. A failing heart muscle cannot pump enough blood into the arteries and tissues to maintain normal body functioning.

Inability to pump blood

Congestive heart failure is the inability of the heart to pump sufficient blood for the body’s needs. It may be due to a weakening of the heart muscle or obstruction of a valve. If the left side of the heart cannot eject all the blood returning from the lungs, blood backs up into the lungs, fluid leaks into the lungs’ air sacs, and breath becomes short and makes crackling sounds (rales). If the right side of the heart cannot adequately accommodate the blood returning from all parts of the body through the veins, blood backs up into the veins. Neck veins distend, the liver enlarges, fluid may accumulate in the abdomen, the feet swell, and body weight increases. Also, the body often retains salt and water because of effects on the nervous sytem, endocrine glands, and kidneys. Excess fluids overload the heart and the circulatory system and make them even more inadequate.

Treatment

Treatment consists of drugs such as digitalis to strengthen and slow heart action and diuretics that cause the kidney to excrete more salt and water. It may also include supplementary oxygen to ease breathing, dietary limitations on salt and fluids, and restrictions on physical activity. Several other older drugs, as well as new ones, are used for treatment.

Thrombophlebitis

Congestive heart failure can cause further complications. The cause of thrombophlebitis is not known, but predisposing conditions include the postpartum state (after giving birth), postoperative periods, fractures, cancer, and infection. The disorder is especially prevalent in patients with congestive heart failure. It can be serious and even lethal if a clot breaks off and moves to the lungs. Although thrombophlebitis can occur without signs or symptoms, common indications are swelling of the leg and discomfort in the calf and inner thigh at rest. It is best diagnosed by noninvasive techniques such as ultrasound and by injecting dye into the veins to outline the clot on X rays (venogram).

BACKGROUND

Since 1999, Actos® has been prescribed as part of an overall treatment regimen for controlling blood sugar in diabetic patients. In recent years it has also been prescribed as a diabetes preventative in those who show the early signs of the disease. In September 2010, the U.S. Food and Drug Administration (FDA) began a safety review of Actos® when new data was discovered that suggested a link to increased risk of bladder cancer.

The risk of bladder cancer is MUCH HIGHER for those that take the drug at higher cumulative doses and for longer periods of time. This increased risk is also greater in men than in women. The FDA has issued a warning of the elevated risk to patients who have been taking Actos®, but added that patients should not stop taking Actos® unless instructed to do so by their physicians. The active ingredient in Actos® is also contained in other drugs, namely Actoplus Met®, Actoplus Met XR®, and Duetact®.

Although Actos® continues to remain on the shelves of drug stores in the United States, the drug is under a long-term observational study by the FDA. France suspended the drug and Germany recommended not to start new patients on the drug due to mounting concerns for their citizens.

RISK OF BLADDER CANCER

In June of this year the U.S. Food & Drug Administration (FDA) issued a warning about the popular diabetes drug Actos(pioglitazone). The FDA had found that the use of pioglitazone for more than a year may be linked to an increased risk of bladder cancer.

SYMPTOMS OF BLADDER CANCER

Common symptoms of Actos®-related bladder cancer may include:

• ■Blood in urine, sometimes creating a change in urine color
• ■Frequent urination
• ■Painful urination
• ■Urinary tract infection

If you or a loved one developed bladder cancer during or after taking Actos®, Actoplus Met®, Actoplus Met XR®, or Duetact®, call us now at 1-800-632-1404 or SUBMIT A SHORT CASE FORM HERE for a free, no obligation, evaluation of your case.

HERE TO HELP.

If you are interested in claims for Actos, an Actos lawsuit, information on an Actos class action, or want to speak with anActos attorney, please call us today at 1-800-632-1404.

Members of our firm are attorneys currently representing clients who have taken several prescription drugs and claim injuries associated with those drugs, including Topamax®, Wellbutrin®, Fosamax®, and Actos®. Members of the firm also represent clients across the globe pertaining to medical device failures, including the Advanced Bionics HiRes90k® cochlear implant , the TVM / TVT transvaginal mesh – sling and the DePuy hip implant. For a free case evaluation, please contact:

CALL US TOLL FREE: (800) 632-1404

EMAIL: click here

FILL OUT THIS FORM:

NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

• Comments

FREE CASE EVALUATION: 1-800-632-1404

Tens of thousands of women receive a transvaginal mesh (TVM) device each and every year from numerous suppliers: American Medical Systems, Bard, Boston Scientific, Ethicon,Gynecare, and Johnson & Johnson.  Thousands of women have been injured through no fault of their own, including vaginal erosion, pain, urinary problems, bleeding, infection and more. Our attorneys are representing women in all fifty states and Canada who have been injured.  For a free case evaluation, call 1-800-632-1404.

We are honored to have two women on staff ready and willing to discuss the facts of your case with you as often as needed.

FDA Issues Mandate

The FDA issued a mandate this week requiring the manufacturers of transvaginal mesh (TVM) products, including American Medical Systems, Bard, Boston Scientific, Ethicon,Gynecare, and Johnson & Johnson, to study the risks and complications of device usage. As a service to the public at large, these are four separate news sources reporting on this pandemic that is affecting thousands of women.

The Food and Drug Administration is requiring these TVM and TVT manufacturers to perform post-market safety studies after a fivefold increase in the number of complications linked to these devices. The manufacturers will study side effects of the devices, including mesh erosion, pain and infection. They must provide data on the effectiveness of transvaginal mesh implants for treating conditions like pelvic organ prolapse and stress urinary incontinence in women.

Approximately 300,000 women underwent transvaginal mesh procedures in 2010, according to the FDA, and many manufacturers are now facing lawsuits for complications involving transvaginal mesh.

Our team of attorneys is reviewing case evaluations for women across the country who have received TVM and TVT products from manufactures such as C.R. Bard, Avaulta, Boston Scientific, and Johnson & Johnson’s Ethicon.

If you need help from a transvaginal mesh device injury, call us today for help.

The Problem

In 2008, the FDA first released concerns about the safety of transvaginal placement of mesh. From 2008 to 2010, the FDA received three to five times as many adverse reports associated with mesh used for pelvic organ prolapse repair than what agency received from 2005 to 2007 (nearly 1,000 reports of adverse events were received from 2005-2007).

Many of these patients complain because of erosion or contraction of the mesh material (which has been described as being of a similar material as Rubbermaid storage containers).  The erosion leads to bleeding, severe pelvic pain, painful (or impossible) sexual performance and a recurrence of urinary problems.

In July 2011, the Food and Drug Administration (FDA) issued an update related to what it called ‘serious complications’ related to the use of vaginal mesh for treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI).  It is now known that complications linked to transvaginal placement of surgical mesh in SUI and POP patients are not rare and can require multiple surgeries to correct problems related to the use of surgical mesh. In fact, the FDA now says that additional surgeries may actually not be able to repair damage caused by implantation of the mesh.

In other words, the side effects of the mesh placement may be permanent.  These complications from transvaginal placement of surgical mesh include:

• -Erosion of the implanted mesh
• -Infection and/or bleeding
• -Pain, including pain during sexual intercourse
• -Problems with organs near the implantation site

Helping You

You may have experienced mesh erosion, bleeding, urinary infections, vaginal scarring, pain during sexual intercourse, failure to conduct sexual intercourse and more. A physician may have tried to remove the mesh and been unable to do so. You may be in excruciating pain, and need help. We are offering free case evaluations to the general public across the United States and Canada. Manufacturers we consider include American Medical Systems, Bard, Boston Scientific, Ethicon,Gynecare, and Johnson & Johnson.

If you received a transvaginal mesh / sling and have been injured, you may be entitled to monetary compensation. Problems include pain, inability to have intercourse,bleeding, mesh growth into the body, mesh erosion, and more. Problems could be irreversible. Please fill out the form to the right or call us so that we can provide you with forms to evaluate your potential case immediately.

We are accepting case evaluations nationwide and in Canada, as well.  Please do not hesitate or delay in contacating TVM / TVT Sling and transvaginal mesh attorneys :

CALL: 1-800-632-1404

EMAIL: clicking here

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

• Comments

FREE CASE EVALUATIONS – FILL OUT FORM TO RIGHT OR CALL TOLL FREE: 1-800-632-1404

Wellbutrin, Paxil and other drugs are commonly prescribed to women who are or may become pregnant for several reasons, including as an antidepressant SSRI aid and as a smoking cessation pill. Regardless of the reason, women who take these drugs may experience a greater than average risk of infant child birth defects, including but not limited to heart defects, cleft palate, cleft lip, skeletal deformations and more. If your child experienced such a horrific side effect, please call us today for a free case evaluation on how we can help.

Listing of Drugs

There are various medications the FDA warns women against taking during different stages of pregnancy. The drugs found on this list went through multiple tests, research experiments, and survey before the FDA classified them as dangerous to babies during pregnancy.

IF YOU HAVE TAKEN ANY OF THESE DRUGS AND YOUR CHILD HAS DEVELOPED A BIRTH DEFECT, PLEASE CONTACT US IMMEDIATELY.

Zoloft (sertraline), a popular antidepressant known as a “selective serotonin reuptake inhibitor” (SSRI), is linked to dangerous side effects in users and serious birth defects (including, heart murmur, hole in the heart and other serious heart defects) if taken by pregnant women. Since 2006, the FDA has warned against the use of Zoloft and other SSRIs in pregnant mothers.

Paxil (paroxetine), one of the most widely prescribed SSRI’s for depression in adults has also been associated with serious side effects in men and women and very dangerous birth defects like heart defects that can result in death if taken by pregnant women. Also part of the 2006 study of SSRI side effects, Paxil has been identified by the FDA to be dangerous for women who are pregnant or who become pregnant.

Prozac (fluoxetine) is probably the most popular anti-depressant and SSRI prescribed by physicians over the past decade and is considered by the FDA to be highly dangerous for women who are pregnant or may become pregnant. Side effects of Prozac include heart defects, cleft palate/cleft lip, and persistent pulmonary hypertension in newborns (PPHN).

Celexa (citalopram), one of the more recent brand-named SSRI’s used to treat depression, was identified by the FDA in 2011 as being linked to very serious side effects as well as birth defects. The FDA issued a warning to adults who took higher dosages of Celexa that they are at a greater risk of deadly heart conditions including fatal heart rhythm problems. Consumer Reports released an article on the study as well.

Wellbutrin (bupropion hydrochloride), was identified by the FDA in 2009 to have links to dangerous side effects and potentially fatal birth defects. A public health advisory was released by the FDA pointing out that Wellbutrin, Chantix and Zyban may increase the risk of suicide and serious neuropsychiatric symptoms.

Lexapro (escitalopram oxalate) is prescribed by doctors to treat depression and generalized anxiety disorder and is in the group of medications classified as SSRIs or selective serotonin reuptake inhibitors. Similar to Zoloft, Paxil and Prozac, Lexapro has been linked to serious and dangerous side effects including thoughts of suicide in adults and heart defects in children from mothers who have taken these products.

Effexor (venlafaxine) is an antidepressant and anti-anxiety drug that was approved by the FDA and released on the market in 2004 as an another SSRI. Since then it has been shown to have a direct correlation with permanent and dangerous birth defects including abdominal birth defects, anal atresia, cardiac defects, limb defects and genital defects.

Diflucan (fluconazole), a powerful anti-fungal medication prescribed to women with yeast infections and other types of fungal infections in the body and organs, may be associated with rare but very serious side effects and birth defects in infants whose mothers were treated with Diflucan. The FDA reported the following possible birth defects: mis-shaped head, cleft palate/cleft lip, joint deformities and congenital heart disease and heart defects.

Topamax (topiramate) is an anti-seizure drug used to treat epileptics and is also prescribed for adults suffering migraine headaches. In 2011, the U.S. Food and Drug Administration strengthened their warning based on new data that links Topamax to severe birth defects when used while pregnant. If you or someone you know has taken or is currently taking Topamax, it is strongly urged by the FDA to discuss alternative treatments for seizures and migraines.

Depakote (divalproex sodium), another popular anti-seizure drug prescribed by doctors to treat epileptic seizures, has been reported in some studies to be linked to severe birth defects and side effects. Birth defects identified in these studies include: holes in the heart, abnormal skull formation, cleft palate/cleft lip, and spina bifida.

If you or someone close to you have taken any of the above drugs and have experienced any of the following birth defects contact our team of Birth Defect Attorneys immediately to discuss your options.

These are some possible birth defects:

Hole in Heart
Heart Defects
Cleft Lip/Cleft Palate
Club Foot, Fetal Death
Anal Atresia
Hypoplastic Left Heart Syndrome (HLHS)
Hypoplastic Right Heart Syndrome (HRHS)Lung Disease/Pulmonary Hypertension
Limb Defect/Genital Defect
Ventrical Outflow Defect
Atrial Septal Defect (ASD)
Tetralogy of the Fallot
Transposition of the Great Arteries
A Ventrical Septal Defect (VSD)
Pulmonary Hypertension in newborn (PPHN)

Anyone who has taken any prescribed medications during pregnancy should discuss their options with a licensed birth defect lawyer immediately. They may be entitled to financial compensation.

Alleged Birth Defects

Anti-depressants have become a troubling subject when it comes to teenagers; however, some mothers are unfortunately giving birth to children with birth defects that may be connected to taking drugs called Selective Serotonin Reuptake Inhibiters (SSRIs) during early pregnancy.

SSRI birth defects, which include heart problems, spina bifida, club foot, cleft pallet, and others, are causing concerning and leading to litigation filed against the makers of these dangerous drugs.

Complaints of SSRI birth defects have been identified since at least 2005 from women who ingested during early pregnancy, Zoloft, Celexa, Lexapro, Paxil, Prozac, and Wellbutrin while pregnant. SSRI drugs are generally used as anti-depressants or to stop smoking.

A New England Journal of Medicine study found that women who took SSRIs during third trimester were six times more likely to deliver babies born with primary pulmonary hypertension (PPHN) than those who did not take the SSRIs during their third trimester.  PPHN is a lung disorder that restricts the arteries and causes blood pressure in the pulmonary artery of the heart to rise beyond control.

Symptoms of PPHN may include the following:  heart murmurs, rapid heart rate, bluish skin, low blood oxygen levels, difficulty breathing diagnosing PPHN.

PPHN is a serious birth defect.  Even after treatment, infants can be susceptible to heart failure, brain hemorrhage, seizures, kidney failure or organ damage.  Some of these birth defects can be present throughout life or even fatal.  Some infants who happen to survive PPHN nevertheless have long term breathing difficulties, seizures, developmental delays and hearing loss.

Zoloft, Celexa, Lexapro, Paxil, Prozac, Wellbutrin and Zyban are anti-depressants or smoking sensation drugs that have fallen under close scrutiny for use by expectant mothers.  As consumers of prescriptions drugs, our society assumes that pharmaceutical companies test for the safety as well as the effectiveness of prescription medication.  Unfortunately, there are and have been several drugs on the market that can cause injury, illness or even death.  In these cases, the negligence of a pharmaceutical company may warrant a personal injury lawsuit.

Such a condition may cause surgery, lifetime defects or death.

Getting Legal Help

If your child is born with a birth defect and you had been prescribed Wellbutrin during pregnancy, you may have a claim for compensation. You may be eligible for compensation for the medical expenses for the treatment of your child and also compensation for your mental sufferings.

If you or a loved one took Wellbutrin during early pregnancy and had a child born with a birth defect, this side effect may be associated with Wellbutrin. Members of our firm are currently reviewing potential Wellbutrin lawsuits. If you have a question or have suffered serious side effects, a Wellbutrin lawyer can be reached by email or by calling TOLL FREE 1-800-632-1404.

Members of our firm are attorneys currently representing clients who have taken several prescription drugs and claim injuries associated with those drugs, includingTopamax®, Wellbutrin®, Fosamax®, and Actos®. They and members of the firm also represent clients across the globe pertaining to medical device failures, including theAdvanced Bionics HiRes90k® cochlear implant , the TVM / TVT transvaginal mesh – sling and the DePuy hip implant. For a free case evaluation, please contact:

TOLL FREE: 1-800-632-1404

EMAIL: click here

FILL OUT THIS FORM:

NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

• Comments

FOR A FREE CASE EVALUATION, CALL 1-800-632-1404

If you took Actos® (pioglitazone) for a year or longer and have been diagnosed with bladder cancer, call the Actos bladder cancer lawyers with our firm at 1-800-632-1404. Our firm is currently reviewing cases involving persons who took Actos® for control of blood sugar.

CONSOLIDATION IN CALIFORNIA

One of the alleged side effects of Actos is bladder cancer. Our team of Actos attorneys is investigating cases to be filed. If you have taken Actos and been diagnosed with bladder cancer, please contact us immediately.

Our team of Actos attorneys wants to point out for the public’s knowledge that Los Angeles Superior Court Judge Carl J. West was appointed by the California Judicial Counsel to be the Coordination Motion Judge during pretrial proceedings in all product liability complaints involving Actos and bladder cancer. This means that all Actos bladder cancer lawsuits filed in California state court, will be consolidated and coordinated during pretrial proceedings.

As our team of Actos injury attorneys have advised in the past on this website, this means that injured persons will be able to shorten the time in all likelihood the recovery of monies they are owed for the alleged side effects and damages they have sustained.

Takeda Pharmaceuticals, the manufacturer of Actos, has indicated it intends to file a motion to transfer all of the California state court lawsuits over Actos to the federal MDL. It is expected that such a motion will be strongly fought by the Plaintiffs.

BACKGROUND

Since 1999, Actos® has been prescribed as part of an overall treatment regimen for controlling blood sugar in diabetic patients. In recent years it has also been prescribed as a diabetes preventative in those who show the early signs of the disease. In September 2010, the U.S. Food and Drug Administration (FDA) began a safety review of Actos® when new data was discovered that suggested a link to increased risk of bladder cancer.

The risk of bladder cancer is MUCH HIGHER for those that take the drug at higher cumulative doses and for longer periods of time. This increased risk is also greater in men than in women. The FDA has issued a warning of the elevated risk to patients who have been taking Actos®, but added that patients should not stop taking Actos® unless instructed to do so by their physicians. The active ingredient in Actos® is also contained in other drugs, namely Actoplus Met®, Actoplus Met XR®, and Duetact®.

Although Actos® continues to remain on the shelves of drug stores in the United States, the drug is under a long-term observational study by the FDA. France suspended the drug and Germany recommended not to start new patients on the drug due to mounting concerns for their citizens.

RISK OF BLADDER CANCER

In June of this year the U.S. Food & Drug Administration (FDA) issued a warning about the popular diabetes drug Actos(pioglitazone). The FDA had found that the use of pioglitazone for more than a year may be linked to an increased risk of bladder cancer.

SYMPTOMS OF BLADDER CANCER

Common symptoms of Actos®-related bladder cancer may include:

• ■Blood in urine, sometimes creating a change in urine color
• ■Frequent urination
• ■Painful urination
• ■Urinary tract infection

If you or a loved one developed bladder cancer during or after taking Actos®, Actoplus Met®, Actoplus Met XR®, or Duetact®, call us now at 1-800-632-1404 or SUBMIT A SHORT CASE FORM HERE for a free, no obligation, evaluation of your case.

HERE TO HELP.

If you are interested in claims for Actos, an Actos lawsuit, information on an Actos class action, or want to speak with anActos attorney, please call us today at 1-800-632-1404.

Members of our firm are attorneys currently representing clients who have taken several prescription drugs and claim injuries associated with those drugs, including Topamax®, Wellbutrin®, Fosamax®, and Actos®. Members of the firm also represent clients across the globe pertaining to medical device failures, including the Advanced Bionics HiRes90k® cochlear implant , the TVM / TVT transvaginal mesh – sling and the DePuy hip implant. For a free case evaluation, please contact:

CALL US TOLL FREE: (800) 632-1404

EMAIL: click here

FILL OUT THIS FORM:

NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

• Comments

FOR A FREE CASE EVALUATION, CALL 1-800-632-1404

If you took Actos® (pioglitazone) for a year or longer and have been diagnosed with bladder cancer, call the Actos bladder cancer lawyers with our firm at 1-800-632-1404. Our firm is currently reviewing cases involving persons who took Actos® for control of blood sugar.

WHAT IS BLADDER CANCER?

One of the alleged side effects of Actos is bladder cancer. Bladder cancer is the second most common kind of urinary tract cancer. It is usually detected because of blood in the urine. This underscores the importance of obtaining a full evaluation by a urologist whenever there is bleeding in the urinary tract. There are a number of risk factors for developing bladder cancer. These include cigarette smoking, side effects of certain drugs like Actos and occupational exposure to certain chemicals and toxins. Unlike many other types of cancer, bladder cancer has a great tendency to recur without spreading to other organs. For this reason, careful surveillance is necessary.

Urinary System and the bladder

The urinary system consists of the two kidneys, the ureters, the bladder, and the urethra. The urinary system includes those organs primarily responsible for cleaning and filtering excess fluid and waste material from the blood, including the kidneys, ureter, bladder and urethra. Just about the time you start adjusting to the fact that you have bladder cancer, you’re faced with another challenge: dealing with your insurance company. If you’re lucky, (1) you have insurance, (2) it’s adequate, and (3) it covers whatever therapy you choose to have. But even if you have a good health care policy, the treatments for bladder cancer can induce sticker shock.

Superficial and Invasive

A simple way of looking at bladder cancer is by dividing it into superficial bladder cancer and invasive bladder cancer, depending on whether or not the tumor has invaded the lamina propria, a thin membrane that separates the mucosa of the bladder from the muscle layer. Superficial bladder tumors, which have not penetrated the muscle layer, have a much better prognosis and are usually treated by surgically removing the tumor and a bit of surrounding tissue or by intavesical chemotherapy (putting medicines directly into the bladder with a catheter). Invasive tumors are usually treated by surgical removal of the entire bladder.

Symptoms

The symptom most commonly associated with cancer of the bladder is the presence of blood in the urine. Although this symptom is typically induced by other benign conditions such as urinary tract infection, bloody urine always warrants investigation, as does any pain experienced during urination. Bladder cancer also infrequently cause other nonspecific symptoms such as weight loss, decreased appetite, and unexplained fevers. Occasionally, kidney cancer causes diffuse pain in the region of the lower back.

BACKGROUND

Since 1999, Actos® has been prescribed as part of an overall treatment regimen for controlling blood sugar in diabetic patients. In recent years it has also been prescribed as a diabetes preventative in those who show the early signs of the disease. In September 2010, the U.S. Food and Drug Administration (FDA) began a safety review of Actos® when new data was discovered that suggested a link to increased risk of bladder cancer.

The risk of bladder cancer is MUCH HIGHER for those that take the drug at higher cumulative doses and for longer periods of time. This increased risk is also greater in men than in women. The FDA has issued a warning of the elevated risk to patients who have been taking Actos®, but added that patients should not stop taking Actos® unless instructed to do so by their physicians. The active ingredient in Actos® is also contained in other drugs, namely Actoplus Met®, Actoplus Met XR®, and Duetact®.

Although Actos® continues to remain on the shelves of drug stores in the United States, the drug is under a long-term observational study by the FDA. France suspended the drug and Germany recommended not to start new patients on the drug due to mounting concerns for their citizens.

RISK OF BLADDER CANCER

In June of this year the U.S. Food & Drug Administration (FDA) issued a warning about the popular diabetes drug Actos(pioglitazone). The FDA had found that the use of pioglitazone for more than a year may be linked to an increased risk of bladder cancer.

SYMPTOMS OF BLADDER CANCER

Common symptoms of Actos®-related bladder cancer may include:

• ■Blood in urine, sometimes creating a change in urine color
• ■Frequent urination
• ■Painful urination
• ■Urinary tract infection

If you or a loved one developed bladder cancer during or after taking Actos®, Actoplus Met®, Actoplus Met XR®, or Duetact®, call us now at 1-800-632-1404 or SUBMIT A SHORT CASE FORM HERE for a free, no obligation, evaluation of your case.

HERE TO HELP.

If you are interested in claims for Actos, an Actos lawsuit, information on an Actos class action, or want to speak with anActos attorney, please call us today at 1-800-632-1404.

Members of our firm are attorneys currently representing clients who have taken several prescription drugs and claim injuries associated with those drugs, including Topamax®, Wellbutrin®, Fosamax®, and Actos®. Members of the firm also represent clients across the globe pertaining to medical device failures, including the Advanced Bionics HiRes90k® cochlear implant , the TVM / TVT transvaginal mesh – sling and the DePuy hip implant. For a free case evaluation, please contact:

CALL US TOLL FREE: (800) 632-1404

EMAIL: click here

FILL OUT THIS FORM:

NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

• Comments

FOR A FREE CASE EVALUATION, CALL 1-800-632-1404

If you took Actos® (pioglitazone) for a year or longer and have been diagnosed with bladder cancer, call the Actos bladder cancer lawyers with our firm at 1-800-632-1404. Our firm is currently reviewing cases involving persons who took Actos® for control of blood sugar.

BACKGROUND

One of the serious side effects of Actos is congestive heart failure. Congestive heart failure is a syndrome characterized by cough, shortness of breath and poor exercise tolerance. Sluggish flow through the lungs leads to fluid accumulation, with a characteristic cough and change in breath sounds heard through a stethoscope. Fluid may accumulate in feet and legs, given a swollen, bloated appearance. Occasionally fluid accumulation can progress to include the torso and body organs. Poor exercise tolerance is an inevitable result of decreased pumping ability of the heart muscle.

Congestive heart failure refers to a condition characterized by the inability of the heart to circulate adequate amounts of blood to the body. As the pump fails, blood backs up into the lungs resulting in shortness of breath. The vital organs are no longer perfused with the necessary amounts of oxygen and other nutrients needed to survive. This leads to multi-system organ failure and death

Treatment

In general, treatment consists of inotropic support where needed, fluid mobilization accomplished by preload reduction, afterload reduction, and relief of ischemia. In terms of drug therapy, this translates into digoxin, diuretics, vasodilators such as hydralazine and nitrates, and ACE inhibitors. In the elderly the effective doses of each are usually lower. The first, digoxin, is given in systolic dysfunction to increase inotropism, or the strength of ventricular contraction. Because of the decrease in renal function that occurs with normal aging, the elderly are at greater risk for digoxin toxicity.

Diuretics

Treatment of congestive heart failure includes fluid elimination by means of diuretics. Diuretics constitute another class of high-risk drugs that should be used with caution in the elderly, in part because of the reduction in total body water with normal aging and other factors. Side effects include hypokalemia possibly linked to sudden death, worsening renal function, left ventricular hypertrophy, and increases in total cholesterol and triglycerides. They may cause a contraction alkalosis. In addition, they may precipitate an exaggerated postural hypotensive response, leading to light‐ headedness, falling, and further morbidity or mortality from a hip or other fracture. Blood pressure and arterial resistance may be altered with a variety of new medications that have yielded outstanding symptom control. In the most serious cases of congestive heart failure, heart transplantation may be necessary.

End stage

Congestive heart failure is the end stage of heart disease. The heart is unable to pump enough blood to supply the vital organs and the body tissues with enough oxygen and nutrients to meet their metabolic demands. It can be the failure of contraction, systolic failure, or the failure of filling, diastolic failure.

BACKGROUND

Since 1999, Actos® has been prescribed as part of an overall treatment regimen for controlling blood sugar in diabetic patients. In recent years it has also been prescribed as a diabetes preventative in those who show the early signs of the disease. In September 2010, the U.S. Food and Drug Administration (FDA) began a safety review of Actos® when new data was discovered that suggested a link to increased risk of bladder cancer.

The risk of bladder cancer is MUCH HIGHER for those that take the drug at higher cumulative doses and for longer periods of time. This increased risk is also greater in men than in women. The FDA has issued a warning of the elevated risk to patients who have been taking Actos®, but added that patients should not stop taking Actos® unless instructed to do so by their physicians. The active ingredient in Actos® is also contained in other drugs, namely Actoplus Met®, Actoplus Met XR®, and Duetact®.

Although Actos® continues to remain on the shelves of drug stores in the United States, the drug is under a long-term observational study by the FDA. France suspended the drug and Germany recommended not to start new patients on the drug due to mounting concerns for their citizens.

RISK OF BLADDER CANCER

In June of this year the U.S. Food & Drug Administration (FDA) issued a warning about the popular diabetes drug Actos(pioglitazone). The FDA had found that the use of pioglitazone for more than a year may be linked to an increased risk of bladder cancer.

SYMPTOMS OF BLADDER CANCER

Common symptoms of Actos®-related bladder cancer may include:

• ■Blood in urine, sometimes creating a change in urine color
• ■Frequent urination
• ■Painful urination
• ■Urinary tract infection

If you or a loved one developed bladder cancer during or after taking Actos®, Actoplus Met®, Actoplus Met XR®, or Duetact®, call us now at 1-800-632-1404 or SUBMIT A SHORT CASE FORM HERE for a free, no obligation, evaluation of your case.

HERE TO HELP.

If you are interested in claims for Actos, an Actos lawsuit, information on an Actos class action, or want to speak with anActos attorney, please call us today at 1-800-632-1404.

Members of our firm are attorneys currently representing clients who have taken several prescription drugs and claim injuries associated with those drugs, including Topamax®, Wellbutrin®, Fosamax®, and Actos®. Members of the firm also represent clients across the globe pertaining to medical device failures, including the Advanced Bionics HiRes90k® cochlear implant , the TVM / TVT transvaginal mesh – sling and the DePuy hip implant. For a free case evaluation, please contact:

CALL US TOLL FREE: (800) 632-1404

EMAIL: click here

FILL OUT THIS FORM:

NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

• Comments

FOR A FREE CASE EVALUATION, CALL 1-800-632-1404

If you took Actos® (pioglitazone) for a year or longer and have been diagnosed with bladder cancer, call the Actos bladder cancer lawyers with our firm at 1-800-632-1404. Our firm is currently reviewing cases involving persons who took Actos® for control of blood sugar.

BACKGROUND

One of the alleged side effects of Actos is bladder cancer. The treatment of bladder cancer is based on the stage and overall condition of the patient. Recently, a court in Los Angeles, California consolidated several proceedings there, which now confirms there are two main sources of litigation for Actos: state court in California and a MDL federal proceeding in the Western District of Louisiana.

During the hearing held in Los Angeles, defendant Takeda stated to the court that it will move to transfer all pending California filed cases to the newly formed federal MDL (multi-district litigation) in the Western District of Louisiana. Plaintiff’s counsel countered this statement, arguing that the current California cases have a legitimate basis for filing in California jurisdiction due to the operations of their Takeda San Diego facility and will seek to oppose Takeda’s efforts to remove California Actos plaintiffs to Federal Court.

Actos (pioglitazone), approved by the FDA to treat type 2 diabetes mellitus, has been at the center of controversy since reports surfaced in June of 2011 linking the drug with a significant risk of bladder cancer. Studies showed that the risk of bladder cancer increased considerably with Actos exposure of longer than one year. The European Medicine Agency and the Federal Institute for Drugs and Medical Devices subsequently suspended the use Actos.

The U.S. Food and Drug Administration (FDA) issued a public announcement on June 15, 2011, alerting the public of the increased risk of bladder cancer associated with Actos. According to the FDA, a 40 percent increased risk for bladder cancer was seen in patients taking Actos for over a year when compared to people not taking the drug.

The agency stated that information about this risk would be added to the labeling of any pioglitazone-containing medication. The FDA further recommended that diabetes patients diagnosed with bladder cancer stop the use of Actos or pioglitazone.

Actos patients should seek legal representation and maximum compensation if they have been diagnosed with bladder cancer or are experiencing urinary bleeding.

BACKGROUND

Since 1999, Actos® has been prescribed as part of an overall treatment regimen for controlling blood sugar in diabetic patients. In recent years it has also been prescribed as a diabetes preventative in those who show the early signs of the disease. In September 2010, the U.S. Food and Drug Administration (FDA) began a safety review of Actos® when new data was discovered that suggested a link to increased risk of bladder cancer.

The risk of bladder cancer is MUCH HIGHER for those that take the drug at higher cumulative doses and for longer periods of time. This increased risk is also greater in men than in women. The FDA has issued a warning of the elevated risk to patients who have been taking Actos®, but added that patients should not stop taking Actos® unless instructed to do so by their physicians. The active ingredient in Actos® is also contained in other drugs, namely Actoplus Met®, Actoplus Met XR®, and Duetact®.

Although Actos® continues to remain on the shelves of drug stores in the United States, the drug is under a long-term observational study by the FDA. France suspended the drug and Germany recommended not to start new patients on the drug due to mounting concerns for their citizens.

RISK OF BLADDER CANCER

In June of this year the U.S. Food & Drug Administration (FDA) issued a warning about the popular diabetes drug Actos(pioglitazone). The FDA had found that the use of pioglitazone for more than a year may be linked to an increased risk of bladder cancer.

SYMPTOMS OF BLADDER CANCER

Common symptoms of Actos®-related bladder cancer may include:

• ■Blood in urine, sometimes creating a change in urine color
• ■Frequent urination
• ■Painful urination
• ■Urinary tract infection

If you or a loved one developed bladder cancer during or after taking Actos®, Actoplus Met®, Actoplus Met XR®, or Duetact®, call us now at 1-800-632-1404 or SUBMIT A SHORT CASE FORM HERE for a free, no obligation, evaluation of your case.

HERE TO HELP.

If you are interested in claims for Actos, an Actos lawsuit, information on an Actos class action, or want to speak with anActos attorney, please call us today at 1-800-632-1404.

Members of our firm are attorneys currently representing clients who have taken several prescription drugs and claim injuries associated with those drugs, including Topamax®, Wellbutrin®, Fosamax®, and Actos®. Members of the firm also represent clients across the globe pertaining to medical device failures, including the Advanced Bionics HiRes90k® cochlear implant , the TVM / TVT transvaginal mesh – sling and the DePuy hip implant. For a free case evaluation, please contact:

CALL US TOLL FREE: (800) 632-1404

EMAIL: click here

FILL OUT THIS FORM:

NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

• Comments